Cite
MLA Citation
Michael W. Bishop et al.. “A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors.” MAbs, vol. 12, no. 1, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100105438663.0x000016